Effect Of Green Tea On Cardiovascular Diseases Biology Essay

Published: Last Edited:

This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.

Tea is the most consumed beverage worldwide aside from water. Among teas, green tea polyphenolshave been extensively studied as cardiovascular disease, since ancient period green tea has been considered a health-promoting beverage. And in recent years, scientists worldwide have evaluated the potential health benefits of green tea and its most abundant catechin, epigallocatechingallate (EGCG).The purpose of the study is to determine the effect of green tea on cardiovascular diseases. Cardiovascular patients, of both sexes, would be randomly selected and followed up, with green tea intake, for two months. Two types of teas would be used in the study, Lipton green tea and locally available green tea, these would also be subjected to proximate analysis and total phenolic contents would also be determined. The variation in nutritive value and phenolic contents among Lipton and local green tea will also be evaluated. The resulting data will be subjected to analysis of variance (Steel et al., 1997). Significant results will be subjected to Duncan Multiple Range Test (Duncan, 1955) to compare the results.



Synopsis for M.Sc (Hons.)Home Economics (Food and Nutrition).

Title: Effect of Green Tea on Cardiovascular Diseases

Date of Admission : 06-10-2011

Date of Initiation : After Approval

Probable Duration : 3 months


1. Name of Student : Sidra Khalid

2. Registration No : 2007-ag-1019

3. Name of Supervisor : Dr. Naheed Abbas


1. Dr. Naheed Abbas (Supervisor)

2. Miss Sana Arif (Member)

3. Prof. Dr. M.AslamMirza (Member)


Cardiovascular disease (CVD) is a main cause of morbidity, disability, and mortality all around the world. Atherosclerotic cardiovascular disease (CVD) is the number one cause of death in the United States and other developed countries (Lloyd et al. 2010). Hyperlipidemia, which results from abnormalities in lipid metabolism, leads to the development of atherosclerotic plaques and is one of the key risk factors of CVD (Jain et al., 2007). Risk of heart attack is 3-fold higher in subjects with hyperlipidemia than in subjects with normal lipid status (Yusuf et al., 2004).

Cardiovascular diseases are recognized as multifactorial diseases. Risk factors for the development of CVD have been identified, which includes older age, male sex, a positive family history, hypertension, diabetes mellitus, dyslipidemia, obesity, andcigarette smoking (Ezzati M., et al 2007). All around the world high cholesterol is one of the major health concerns affecting people. According to the World Health Organization, about 39% of the people worldwide cholesterol (WHO, 2013).

Cholesterol is one of thecardinal substances in sustaining the normal functions of the body, including the cell structures and manufacturing of hormones. High cholesterol, can lead to increased risk of heart disease and stroke. High cholesterol treatments target Low Density Lipoprotein (LDL), which is often referred to as the "bad cholesterol". LDL is known as "bad" because it transport cholesterol from the liver to body cells and often results in plaque formation in the arteries(National Heart Lung and Blood Institute, 2012).

Many clinical trials show an increased risk of heart disease when there is an elevated level of LDL, making LDL the primary target of therapy (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2011).Oxidation of LDL is thought to play an important role in the atherogenesis. In the initial stages of atherosclerosis, LDL accumulates in the intima of lesion-prone sites of the arterial wall (Schwartz et al., 1991).

The possible involvement of oxidative processes early in atherogenesis has stimulated the idea that dietary antioxidants may have a preventive effect in cardiovascular disease (Gey, 1995). Epidemiological data and randomized trials indicate a protective role of dietary oxidants against CVD (Stephens et al., 1996). Flavonoids derived from tea have been demonstrated to efficiently scavenge a variety of free radicals. Indeed, the potent antioxidant properties of tea polyphenols are thought to be one of the mechanisms underlying their putative protective action against CVD. When the complex nature of atherosclerosis is considered, tea may have a protective role against CVD via a number of different mechanisms, one of which is its antioxidant activity. (Report of the Dietary Guidelines Advisory Committee, 2010).

Tea is the most consumed beverage in the world besides water. Consumption of tea is in the forms of green, oolong, and black tea, which are originated from the leaves of the plant Camelliasinensis. Green tea polyphenols have been extensively studied as reducing cardiovascular disease (CVD) agents (Zaveri, 2006; Cooper et al., 2005). Green tea is prepared by drying, not fermenting, freshly harvested tea leaves and therefore contains more antioxidants than fermented teas. Freshly harvested leaves are immediately steamed to prevent fermentation, yielding a dry, stable product, steaming process destroys the enzymes responsible for breaking down the color pigments in the leaves and allows the tea to maintain its green color during the manufacturing processes. As green tea is fermented to oolong and then to black tea, polyphenol compounds (catechins) in green tea are dimerized, such that these teas may have different biological roles (Cheng, 2000).

Approximately 2.5 million tons of tea leaves are produced annually worldwide, with 20% produced as green tea, which is consumed in Asia, some regions of North Africa, the United States, and Europe. Green tea has been found beneficial than black tea in terms of antioxidant activity due to the higher content of (−)-epigallocatechingallate (Cheng, 2000). Catechins, a class of low molecular weight polyphenols, are major polyphenols of green tea, which comprises of one third of total dry weight of green tea. Green tea contains poly phenolic compounds, (-)-epigallocatechin-3-gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG) and (-)-epicatechin (EC). The major catechin is (−) epigallocatechin-3-gallate (EGCG). The biological effects of tea polyphenols are focused on the effects of EGCG, including the prevention of LDL oxidation, reduction of platelet aggregation, lipid regulation, and inhibition of proliferation and migration of smooth muscle cells (Cabrera et al ., 2006).

The cardio-protective effect of flavonoids from green tea can be attributed to not only antioxidant, anti-thrombogenic and anti-inflammatory properties but also improvement of coronary flow velocity reserve (Hirata et al., 2004; Cheng, 2004). The beneficial effect of green tea against atherosclerosis has been referred to the antioxidant activity of the flavonoids (Rietveld and Wiseman., 2003). Antioxidants are compounds that protect cells against the damaging effects of reactive oxygen species such as free radicals. An imbalance between antioxidants and reactive oxygen species results in oxidative stress, leading to cellular damage. Catechins are hypothesized to help protect against these diseases by contributing, along with antioxidant vitamins and enzymes, to the total antioxidant defense system (Abdel-Raheimet al., 2009).

Chinese green tea has been shown to significantly prevent endothelial-cell induced LDL oxidation and suppress lipoxygenase activity. Because LDL oxidation is a characteristic feature of atherogenesis and lipoxygenase is involved in the process, the intake of green tea, hence, reduces the risk of coronary heart disease. Green tea has also been shown to lower plasma cholesterol by increasing fecal bile acids and cholesterol (Yang and Koo., 2000). Green tea also has an anti-inflammatory effect (Cheng., 2003). Green tea might be a preventive agent for chronic inflammatory diseases (Sueokaet al., 2001).

Green tea catechins affect lipid metabolism by different pathways and prevent the appearance of atherosclerotic plaque. Its intake decreases the absorption of triglycerides and cholesterol and these findings are in accordance with the fact that it increases excretion of fat (Raederstorffet al., 2003).


The project at hand has been planned:

To determine and compare the nutritive value, along with total phenolic contents, of Lipton green tea and locally available green tea.

To examine the effect of green tea on cardiovascular diseases.

To compare the consequences of both Lipton green tea and locally available green tea on cardiovascular diseases.


Miura et al., (2000) conducted an experiment, to examine the intake of green tea polyphenols renders LDL resistant to ex vivo oxidation in humans' male volunteers were assigned the same dietary pattern. They were equally divided into two groups: control and tea. The tea group ingested 300 mg of green tea polyphenol extract twice daily. Plasma concentrations of lipids, ascorbate, α-tocopherol, and lipid peroxides did not change before and after the experiment in either group, but β-carotene was higher in the tea group. These results suggested that daily consumption of seven to eight cups (approximately 100 mL each cup) of green tea might increase resistance of LDL to in vivo oxidation, leading to lowering the risk of cardiovascular diseases.

Erbaet al., (2005) investigated the effect of the addition of two cups of green tea (containing approximately 250 mg of total catechins) to a controlled diet in a group of healthy adults with respect to a group following the same controlled diet but not consuming green tea. Antioxidant status and lipid profile in plasma were measured at the beginning and at the end of trial. Consumption of GT caused a significant increase in plasma total antioxidant activity, significant decreases in plasma peroxides level and induced DNA oxidative damage in lymphocytes), a moderate although significant decrease in LDL cholesterol with respect to control. The study suggested the ability of GT, consumed within a balanced controlled diet, to improve overall the anti-oxidative status and to protect against oxidative damage in humans.

Zaveri, (2005) reported that the use of green tea as a cancer chemo preventive or for other health benefits has been confounded by the low oral bioavailability of its active poly phenolic catechins, particularly epigallocatechin-3-gallate (EGCG), the most active catechin. This review summarized the purported beneficial effects of green tea and EGCG in various animal models of human diseases. Dose-related differences in the effects of EGCG in cancer versus neurodegenerative and cardiovascular diseases, as well as discrepancies between doses used in in vitro studies and achievable plasma understanding of the in vivo effects of green tea catechins in humans, before the use of green tea is widely adopted as health-promoting measure.

Ohmoriet al., (2005) studied to enlighten whether green tea consumption may have these effects in vivo or not, which may be beneficial against atherosclerosis. Green tea has shown to inhibit LDL oxidation, platelet aggregation, and matrix metallo proteinases (MMPs) actions in vitro. They measured serum malondialdehyde-modified LDL (MDA-LDL) concentrations and urine 8-epi-prostaglandin in healthy nonsmokers male. They drank 7 cups of water daily for couple of weeks and drank 7 cups of green tea daily for the next weeks. They concluded that daily consumption of green tea decreased serum MDA-LDL concentrations, but it had no significant effects on platelet aggregation, platelet TX production or plasma MMPs concentrations. Other results suggested that green tea consumption also inhibit LDL oxidation in vivo.

Cheng. (2006) reported that tea is one of the most widely consumed beverages in the world, besides water. It can be categorized into three types, depending on the level of fermentation, i.e., green (unfermented), oolong (partially fermented) and black (fermented) tea. Green tea has been found to be superior to black tea in terms of antioxidant activity owing to the higher content of (−)-epigallocatechingallate. The processes used in the manufacture of black tea are known to decrease levels of the mono-metriccatechins to a much greater extent than the less severe conditions applied to other teas. The cardio-protective effect of flavonoids from green tea can be attributed to not only antioxidant, anti-thrombogenic and anti-inflammatory properties but also improvement of coronary flow velocity reserve. He discussed the effects of green tea on atherosclerosis, coronary heart disease, hypertension, diabetes, metabolic syndrome and obesity, and, finally, its comparison with black tea.

Kuriyamaet al., (2006) performed an experiment on adults without history of stroke, coronary heart disease, or cancer to investigate the associations between green tea consumption and mortality due to cardiovascular diseases, cancer, and all causes. Green tea consumption was inversely associated with mortality due to all causes and due to cardiovascular diseases. The inverse association with all-cause mortality was stronger in women than that of men. In men, the ratio of mortality due to all causes was associated with different green tea consumption. The inverse association with cardiovascular disease mortality was stronger than that with all-cause mortality. Among the types of cardiovascular disease mortality, the strongest inverse association was observed for stroke mortality. In contrast, the hazard ratios of cancer mortality were not significant.

Cabrera et al. (2006) reviewed that tea is the most consumed drink in the world besides water. Green tea is a 'non-fermented' tea, and contains more catechins, as compared to black tea or oolong tea. Catechins are in vitro and in vivo strong anti-oxidants, its content of certain minerals and vitamins increases the antioxidant potential. Since ancient times, green tea has been considered by the traditional Chinese medicine as a healthy beverage. Recent human studies suggest that green tea may contribute to reduction in the risk of cardiovascular disease and some forms of cancer, as well as to the promotion of oral health and other physiological functions such as anti-hypertensive effect, obesity control, antibacterial and anti-viral activity, increase in bone mineralization, anti-fibrotic properties, and neuro protective power. Increasing concern in its health benefits has led to the inclusion of green tea in the group of beverages with functional properties.

Koo and Noh, (2007) evidenced from in vitro and in vivo studies that green tea or catechins inhibit the intestinal absorption of dietary lipids. Studies in vitro indicate that green tea catechins, particularly (−)-epigallocatechingallate, interfere with the emulsification, digestion, and solubility of lipids, critical steps involved in the intestinal absorption of dietary fat, cholesterol, and other lipids. Animal and epidemiological studies suggested that green tea catechins may reduce the risk of cardiovascular diseases e.g., coronary heart disease (CHD). The health benefit of green tea had been attributed to its antioxidant and anti-inflammatory properties; however, considerable evidence suggested that green tea and its catechins may reduce the risk of CHD by lowering the plasma levels of cholesterol and triglyceride. Green tea reduced the absorption and tissue accumulation of other lipophilic organic compounds. The available information suggests that green tea or its catechins might be used as safe and effective lipid-lowering therapeutic agents.

Khan and Mukhtar, (2007) reported that although health benefits have been attributed to tea, especially, green tea consumption since many years, scientific investigations of this beverage and its constituents have been underway for less than three decades. People have been consuming brewed tea from the leaves of the Camellia sinensisplant for almost 50 centuries. Currently, tea, in the form of green or black tea, is the most widely consumed beverage in the world. In vitro and animal studies provide strong evidence that polyphenols derived from tea may possess the bioactivity to affect the pathogenesis of several degenerative diseases. Among all tea polyphenols, epigallocatechin-3-gallate of green tea has been shown to be responsible for much of the health promoting ability. Tea and tea preparations have been shown to inhibit tumor formation in a variety of animal models of carcinogenesis.

Wolfram, (2007) suggested that dose-response relationships observed in several epidemiological studies have suggested that pronounced cardiovascular and metabolic health benefits can be obtained by regular consumption of 5-6 or more cups of green tea daily. Intervention studies using similar amounts of green tea, containing 200-300 mg of EGCG, have demonstrated its usefulness for maintaining cardiovascular and metabolic health. Additionally, there are numerous in vivo studies demonstrating that green tea and EGCG exert cardiovascular and metabolic benefits. Therefore, green tea and EGCG can be regarded as food components useful for the maintenance of cardiovascular and metabolic health. To prove the effectiveness for disease prevention or treatment, long-term clinical studies investigating the effects of one precisely-defined green tea product on cardiovascular and metabolic endpoints would benecessary.

Nagao et al, (2007) investigated the effect of green tea catechins in reducing body fat and risk of cardiovascular by in randomly collected Japanese men and women. The individuals were ingested 96-583 mg of green tea catechins daily with normal dietary intake and usual physical activity. The continuous ingestion of green tea high in catechins resulted in body fat, LDL cholesterol and systolic blood pressure, indicating that green tea high in catechins in take results in decrease obesity and cardiovascular risks.

Tinahoneset al. (2008) studied to determine the effect of a green tea extract on vascular function and lipid peroxidation as compared with placebo. The study was carried out with healthy women, none of them were receiving any medical treatment. The consumption of green tea extract was associated with a significant 37.4% reduction in the concentration of oxidized LDL. This study found that consumption of green tea extract by women results in modifications in vascular function and a considerable decrease in serum oxidation.

Chackoet al. (2010) investigatedthe health benefits of green tea for a wide variety of conditions, including cancer, heart disease, and liver disease due to beneficial effects of green tea catechin, particularly (-)-epigallocatechin-3-gallate, content. They related the healthful mechanisms of green tea catechins by evidences from in vitro, animal and human studies. As there were also on using green tea catechins to treat metabolic syndrome, such as obesity, type II diabetes, and cardiovascular risk factors. And they suggested that long term consumption of green tea catechins could be beneficial against high-fat diet-induced obesity and type II diabetes and to reduce the risk of heart disease.

Mineharuet al., (2011) studied to examine the relationship between the consumption of these beverages and risk of mortality from CVD, individuals aged 40-79 years free of stroke, coronary heart disease (CHD) and cancer at early stage were prospectively followed. The daily consumption of beverages was assessed by questionnaires. They concluded that consumption of coffee, green tea and oolong tea and caffeine intake was associated with a lower risk of mortality from CVD.

Zhenget al. (2011) identified the effect of green tea and its extract on total cholesterol (TC), LDL cholesterol, and HDL cholesterol. They identified relevant trials of green tea beverages and extracts on lipid profiles in adults. Weighted mean differences were calculated for net changes in lipid concentrations by using fixed-effects or random-effects models. The analysis of studies showed that the consumption of green tea beverages resulted in significant reductions in serum TC and LDL-cholesterol concentrations, but no effect on HDL cholesterol was observed. Analyses showed that these changes were not influenced by the type of intervention, dose of green tea, study duration, individual health status, or quality of the treatment study.


It would be a clinical comparative study in which the nutritive value (Proximate analysis) and clinical consequences (on cardiovascular patients having normal routine diet),ofLipton green tea as well as locally available green tea, would be determined after a follow up of 2 months.

Sample Size:

Total 21 patients, of both sexes, will be selected randomly. The selected patients would be further divided into three groups as:

Group-1: No treatment would be given to 7 patients (control Group).

Group-2: Lipton green tea would be given to 7 patients.

Group-3: Locally available green tea would be given to 7 patients.

Area of Research:

Clinical Trials:

21 patients of cardiovascular diseases, for a follow up of two months with green tea intake, would be randomly selected,from Punjab Institute of Cardiology, Lahore.

Laboratory Analysis:

Green tea samples, of both teas, will be brought and processed in the Nutrition Research Laboratory of theNational Institute of Food & Technology, University of Agriculture, Faisalabad.

Proximate Analysis

The proximate analysis of green tea (Lipton and local tea), for protein, fat, crude fiber, ash and soluble carbohydrates will be done by using the method given by AOAC(1990).

Phenolic content Analysis:

The total number of phenolic contents of both Lipton green tea and locally available green tea, will be determined.

Statistical Analysis

The resulting data will be subjected to analysis of variance (Steel et al., 1997). Significant results will be put to Duncan Multiple Range Test (Duncan, 1955) to compare and interpret the results.


Abdel-Raheim, M. A.M., A.H. Enas and A.E. Khaled, 2009.Effect of green tea extract and vitamin c on oxidant or antioxidant. Indian J ClinBiochem., 24:280-87.

AOAC. 1990. Methods of Analysis. The Association of Official Analytical Chemists.15th Ed. Arlington, Virginia 22201, U.S.A.

Bartlett, A.H., 2004. Fine teas flower in the bay area. N.Y. Times 8.

Cabrera, C., R. Artacho, R. Gimenez, 2006.Beneficial effects of green tea-a review. J Am Coll Nutr.,25:2 79-99

Cheng, T.O. 2003. Why did green tea not protect against coronary artery disease but protect against myocardial infarction?. Am J Cardiol 91: 1290-1291.

Cheng, T.O., 1999. Antioxidants in wine and tea. J R Soc Med., 92:157.

Cheng, T.O., 2000. Tea is good for the heart. Arch Intern Med., 160:2397.

Cheng, T.O., 2004. Will green tea be even better than black tea to increase coronary flow velocity reserve? Am J Cardiol., 94:1223.

Cheng, T.O., 2006.All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol., 108:301-8.

Cooper, R., D.J. Morre and D.M. Morre, 2005. Medicinal benefits of green tea, I: review of noncancer health benefits. J Altern Complement Med., 11:521-528.

Duncan, D.B. 1955. Multiple Ranges and Multiple F-tests.Biometrics. Vol. 11 (1):1-42.

Erba, D., P. Riso, A. Bordoni, P. Foti, P. Biagi and G. Testolin, 2005.Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans.The Journal of Nutritional Biochemistry, 16:144-149.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001.Executive summary of the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III).JAMA, 285:2486-97.

Ezzati, M., A. D. Lopez, A. Rodgers and C. J. L. Murray, 2004. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. World Health Organization, 1:1-38.

Gey, K.F., 1995. Ten year retrospective on the antioxidant hypothesis of atherosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J. Nutr. Biochem.6: 206-236.

Hertog, M.G., 1996. Epidemiological evidence on potential health properties of flavonoids. Proc Nutr Soc., 55:385-397.

Hertog, M.G., E.J. Feskens, P.C. Hollman, M.B. Katan and D. Kromhout. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. The Lancet 342:1007-1011.

Hirata K., K. Shimada, H. Watanabe, R. Otsuka, K. Tokai, M. Yoshiyamaet al. 2004. Black tea increases coronary flow velocity reserve in healthy male subjects. Am J Cardiol 93:1384- 388.

Ho, C.-T., Q.Y. Chen, H. Shi, K.-Q. Zhang and R.T. Rosen, 1992. Antioxidant effect of polyphenol extract prepared from various Chinese teas. Prev Med., 21:520-525.

Jain, KS., M.K. Kathiravan, R.S. Somani and C.J. Shishoo, 2007. The biology and chemistry of hyperlipidemia.Bioorg Med Chem., 15: 4674-99.

Khan, N. and H. Mukhtar, 2007.Tea polyphenols for health promotion.Life Sciences, 81:519 -33.

Koo,S. I. andS. K. Noh, 2007.Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. The Journal of Nutritional Biochemistry, 18:179-83.

Kris-Etherton, P. M. and C.L. Keen, 2002.Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health.CurrOpinLipidol., 13: 41-49.

Kuriyama, S., T. Shimazu, K. Ohmori, N. Kikuchi, N. Nakaya, Y. Nishino, Y. Tsubono and I. Tsuji, 2006.Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan.American Medical Association, 196:1255-1265.

Lloyd-Jones, D., R.J. Adams, T.M. Brown, et al., 2010. Heart disease and stroke statistics: a report from the American Heart Association, 121:46-215.

Mineharu, Y., A. Koizumi, Y. Wada, H. Iso, Y. Watanabe, C. Date, A. Yamamoto, S. Kikuchi, Y. Inaba, H. Toyoshima, T. Kondo, A. Tamakoshi,and the JACC study group, 2011. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women.J Epidemiol Community Health.,65:230-240

Miura, Y., T. Chiba, S. Miura, I. Tomita, K. Umegaki, M. Ikeda and T. Tomita, 2006.Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. The Journal of Nutritional Biochemistry, 11:216-222.

Nagao, T., Y. Komine, S. Soga, S. Meguro, T. Hase, Y. Tanaka and I. Tokimitsu, 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J ClinNutr.,81:122-129.

Naoko, S., M. Suganuma, E. Sueoka, S. Okabe, S.Matsuyama, K. Imai, K. Nakachi and H. Fujiki, 2001. A new function of green tea: Prevention of lifestyle-related diseases. Annals of the New York Academy of Sciences, 928:274-80.

Ohmori, R.,R. Takahashi,Y. Momiyama, H. Taniguchi, A. Yonemura. S. Tamai, K. Umegaki, H. Nakamura, K. Kondo and F. Ohsuzu, 2005. Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects.J Am Coll Nutr.,24:342-346.

Raederstorff, D.G., M.F. Schlachter, V. Elste and P. Weber, 2003.Effect of EGCG on lipid absorption and plasma lipid levels in rats. Journal of Nutritional Biochemistry, 14:326-332.

Raised Cholesterol, 2013.World Health Organization.

Report of the Dietary Guidelines Advisory Committee, 2010.

Rietveld, A. and S. Wiseman, 2003. Antioxidant effects of tea: evidence from human clinical trials. J Nutr., 133:3285-3292.

Schwartz, C.J., A.J. Valente, E.A. Sprague, J.K. Kelley, and R.M. Nerem, 1991. The pathogenesis of atherosclerosis: an overview. Clin.Cardiol., 14:1-16.

Steel, R.G.D., J.H. Torrie and D.A. Dickey. 1997. Principles and Procedures of Statistics. 3rd Ed. McGraw Hill Book Co. Inc. New York.

Stephens, N.G., A. Parsons, M.J. Brown, P.M. Schofield, F. Kelly, K. Cheeseman and Mj.Mitchinson, 1996.Randomized controlled trial of vitamin E in patients with coronary heart disease: Cambridge Heart Antioxidant Study. The Lancet, 347:781-786.

Tinahones, F. J., M. A. Rubio,L. Garrido-Sanchez, E. Gordillo and L. Cabrerizo, 2008. Green tea reduces LDL oxidability and improves vascular function. Journal of the American College of Nutrition, 27:209-213.

Vinson, J.A., 2000. Black and green tea and heart disease: a review. Biofactors, 13:127-132. What is Cholesterol? 2012. National Heart Lung and Blood Institute.

Wolfram, S., 2007.Effects of green tea and EGCG on cardiovascular & metabolic health. Journal of the American College of Nutrition, 26:373-388.

Yang, T.T., Koo, M.W., 2000. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sciences, 66:411-423.

Yusuf, S., S. Hawken, S. Ounpuu, et al,. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 364:937-52.

Zaveri, N. T., 2006. Green tea and its polyphenoliccatechins: medicinal uses in cancer and noncancer applications. Life Sci., 78:2073-2080.

Zheng, X., Y. Xu, S. Li, X. Liu, R. Hui, X. Huang, 2011. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. American Journal of Clinical Nutrition, 94:601-10.